Lack of effectiveness of dexamethasone in neonatal bacterial meningitis

European Journal of Pediatrics

Volumn 158, Issue 3, 1999, Pages 230-233

  Daoud, A S ^a   Batieha, A ^c   Al Sheyyab, M ^a   Abuekteish, F ^a   Obeidat, A ^b   Mahafza, T ^c  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b Neonatal U of Prncs Badia T   (Jordan)

^c NONE

Author keywords

Bacterial meningitis; Dexamethasone; Neonate

Indexed keywords

AMPICILLIN; CEFOTAXIME; DEXAMETHASONE;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; NEWBORN INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTI-BACTERIAL AGENTS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MENINGITIS, BACTERIAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033003268     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310051056     Document Type: Article

References (16)

1. 1. Bessler H, Straussberg R, Gurary N, Aloni D, Sirota L (1996) Effect of dexamethasone on IL-2 and IL-3 production by mononuclear cells in neonates and adults. Arch Dis Child 75:F197-F201
2. 2. Boumpas DT, Paliogianni F, Anastassiou ED, Balow JE (1991) Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol 9:413-423
3. 3. Daoud AS, Al-Sheyyab M, Abu-Ekteish F, et al (1996) Neonatal meningitis in Northern Jordan. J Trop Pediatr 42:267-270
4. 4. Dubowitz L, Dubowitz V (1981) The neurological assessment of the premature and full-term infant. Clin Dev Med 79. SIMP. London
5. 5. Hristeva L, Booy R, Bowler I, Wilkinson AR (1993) Prospective surveillance of neonatal meningitis. Arch Dis Child 69:14-18
6. 6. Kuenzle C, Baenzigner O, Martin E, et al (1994) Prognostic value of early MR imaging in terms infants with severe perinatal asphyxia. Neuropaediatrics 4:191-200
7. 7. Lebel MH, Freij BJ, Syrogiannopoulos GA, et al (1988) Dexamethasone therapy for bacterial meningitis: results of two double-blind, placebo-controlled trials. N Engl J Med 319:964-971
8. 8. McGowan JE Jr, Chesney PJ, Crossley KB, La Force FM (1992) Guidelines for the use of systemic glucocorticosteriods in the management of selected infections. J Infect Dis 165:1-13
9. 9. Odio CM, Faingezicht I, Paris M, et al (1991) The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 324:1525-1531
10. 10. Prober CG (1995) The role of steroid in the management of children with bacterial meningitis. Pediatrics 95:29-31
11. 11. Quagliarello V, Scheld WM (1992) Bacterial meningitis: pathogenesis, pathophysiology and progress. N Engl J Med 327:864-872
12. 12. Report of the Committee on Infectious Diseases of the American Academy of Pediatrics (1994) Dexamethasone therapy for bacterial meningitis in infants and children, 23rd edn. American Academy of Pediatrics, EIK Grove Village, Ill., pp 558-559
13. 13. Schaad UB, Lips U, Gnehm HE, et al (1993) Dexamethasone therapy for bacterial meningitis in children. Lancet 342:457-461
14. 14. Wald ER, Kaplan SL, Mason EO, et al (1995) Dexamethasone therapy for children with bacterial meningitis. Pediatrics 95:21-28
15. 15. Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV and the Bacterial Meningitis Study Group (1990). Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis 162:1316-1323
16. 16. Yu JS, Grauaug A (1963) Purulant meningitis in the neonatal period. Arch Dis Child 38:391-396